aXichem publishes the study results from its clinical study of aXivite, targeting weight control, proving significant effect in decrease of body fat
aXichem AB (publ), a developer of natural analogue industrial compounds, today publishes the study report from the clinical study of aXichem’s phenylcapsaicin product, aXivite , carried out at Center for Applied Health Sciences in Canfield, Ohio, US. The result was previously commented in a press release on June 2[nd], 2021. Report summary and conclusion: aXivite (phenylcapsaicin) is a novel functional ingredient derived from the natural compound, capsaicin.